Therapies and Diagnostics for Uterine Cancer

Sep 2013| HLC142A| BCC Publishing
Ask a Question

Report Highlights

The global market for uterine cancer treatments and diagnostics reached $17.4 billion in 2012. This market is expected to grow to nearly $17.8 billion in 2013 and then to nearly $21.6 billion in 2018, a compound annual growth rate (CAGR) of 3.9% over the five-year period from 2013 to 2018.

Report Includes

  • An overview of the global market for diagnostics and therapies for uterine cancer
  • Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018
  • A breakdown of the markets by diagnostics and screening, surgery, radiation therapy, and drug therapy
  • Discussion of uterine cancer biology
  • Delineation of drugs approved and in the pipeline to treat the disease, including chemotherapeutic and immunotherapeutic
  • Evaluation of the patent landscape
  • Comprehensive profiles of key companies.

SCOPE OF THE STUDY

The scope of this study is diagnostic test and therapeutic markets for uterine cancers. Screening tests are included as discussion only, as new studies have reflected that Pap smears, CT scans and ultrasound could be used as screening aids for uterine cancer. The exact usage for these tests for uterine cancer is still under research; therefore, sales numbers and revenue forecasts from this segment are not included in the final market summary. The focus of this report is on diagnostic tests and therapeutics for uterine cancer, including surgery and diagnostic methods (e.g., hysteroscopy and endometrial biopsy) that are currently in use. The report also includes discussions on the current technologies, new technologies, incidence, market projections and market share, along with the latest trends and new developments.

ABOUT THE AUTHOR

Usha Nagavarapu is an experienced pharmaceutical professional with scientific and business development experience. She has managed preclinical discovery programs from target identification, including Investigational New Drug (IND) enabling studies, and assisted out-licensing and portfolio development activities. Her strong focus areas include oncology, dermatology and cardiovascular diseases. She has extensive experience working with early start-ups to fulfill operational obligations while minimizing overall operational cost and burden.

Table of Contents & Pricing

All reports provided in PDF format. For shared licensing options (5+ Users), please call a representative at (+1) 781-489-7301 or contact us at info@bccresearch.com
Title/Chapter Name Pages Price Member Price
Full Report: Therapies and Diagnostics for Uterine Cancer 169 $2,750 Free
Chapter- 1: INTRODUCTION4Free
Chapter- 2: SUMMARY3$250Free
Chapter- 3: OVERVIEW20$325Free
Chapter- 4: UTERINE CANCER: BIOLOGY12$195Free
Chapter- 5: UTERINE CANCER DIAGNOSIS AND SCREENING8$130Free
Chapter- 6: UTERINE CANCER TREATMENT STRATEGIES18$293Free
Chapter- 7: UTERINE CANCER INCIDENCE20$325Free
Chapter- 8: GLOBAL MARKET FOR UTERINE CANCER TREATMENTS AND DIAGNOSTICS30$488Free
Chapter- 9: TREATMENT MARKET40$651Free
Chapter- 10: PATENT LANDSCAPE3$49Free
Chapter- 11: SELECTED COMPANY PROFILES8$130Free
Chapter- 12: BIBLIOGRAPHY3$49Free

When do I get the report?
Most reports are fulfilled immediately. In some cases, it could take up to 24 hours.

In what format does this report get delivered to me?
We will send you an email with login credentials to access the report. You will also be able to download the pdf.

What are the free reports included in my purchase?
They consist of a collection of current reports from various partner publishers scanning multiple industries.

What is the difference between BCC Research and BCC Publishing?
BCC Research curates thousands of reports from different sources and provides access to this content to our clients. BCC Publishing is the publication arm of BCC Research (one of several publishers in our portal).

What reports do I get 'discounts' on with my purchase?
All reports. BCC Publishing reports will be available for a 50% discount. All other partner publishers are also available at deeply discounted rates.

Where are you located?
Wellesley Massachusetts, just outside of Boston, Massachusetts, USA.

How long has BCC Research been around?
We are approaching our 50 year anniversary in 2021!

What if I want you to invoice me for payment via Purchase Order?
Simply choose Pay by Purchase Order when you are checking out. We will connect with you via email to set up your order.

What if I have a question about your reports?
Call us, email us, or chat with us! We encourage your questions and feedback. We have a research concierge team available at all times, and included in every purchase, to help our customers find the research they need-when they need it.

Can I share this report with my team?
Absolutely yes, with the purchase of additional user licenses.

Can I use your research in my presentation?
Absolutely yes, so long as the publisher is properly cited.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
RELATED REPORTS
Share This Report